Pozen Inc.’s (POZN) Chief Executive Officer Presents at UBS Global Life Sciences Conference
John R. Plachetka, the chairman and chief executive officer of POZEN Incorporated (NASD: POZN), a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs, presented earlier this week at the UBS Global Life Sciences Conference in New York, New York. The company’s research and development efforts are focused primarily on the development and commercialization of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. The company focuses on providing therapeutic advancements that can improve efficacy, safety, and/or patient convenience. POZEN currently has development and commercialization alliances with GlaxoSmithKline for Treximet™, a…